Candidate of Biological Sciences
Director of the Phystech School of Biological and Medical Physics


Denis V. Kuzmin

Reception hours:
Monday: 12:00-13:00
Write to the mail


2017-2019: Moscow School of Management SKOLKOVO. MBA.

2007-2011: M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Laboratory of Structure and Function of Human Genes. Candidate of Biological Sciences, specialty "Molecular Biology".

2002-2007: Lomonosov Moscow State University, specialty "Biochemistry".

Knowledge of languages:

Russian – native

English – fluent

Professional experience:
Viridias LLC (RUSNANO portfolio company). CEO. A biotech startup for the development and introduction into clinical practice of a new generation of antibiotics against methicillin-resistant staphylococcus. The company has successfully attracted funding from the I2BF-Rusnano Strategic Recourses Fund and the Skolkovo Foundation. Within the framework of the Start-Up Village, the Viridias project took second place among all participants of the competition (2017).
LLC "Solixant" (RUSNANO portfolio company). CEO and member of the Board of Directors. Organization of the activities of the Russian division of the American company Solix Ingredients Inc.; implementation of technology transfer in the Russian Federation – import and localization of Solix photobioreactors of the Lumia AGS260 series, which have no analogues in the Russian Federation; organization of screening of microalgae strains from the collection of all leading research institutes for the presence of substances with high potential for commercialization in the field of biologically active additives.
Solixant LLC was successfully allocated into an independent company and attracted funding from the I2BF-Rusnano Strategic Recourses Fund and the Skolkovo Foundation. As part of the activities of Solixant LLC, the Pond Superfoods spin-off project was launched – the production of a biologically active additive based on spirulina. The product was brought to the largest retail and pharmacy chains of the Russian Federation.
Educational and Scientific Center of IBH RAS. Head of the scientific group. Development of antitumor drugs of molecular-directed action based on antimicrobial peptides of animals.

Independent laboratory "INVITRO". Working on a franchise model.

Creation and management of the development of large centers, attraction of investments, financial and strategic planning; bringing to the market statistical data of molecular genetic studies of diagnostics; launch and implementation of federal programs with the Ministry of Health and Social Development.

Main publications:
  1. Rabushko E, Sorokin M, Suntsova M, Seryakov AP, Kuzmin DV, Poddubskaya E, Buzdin AA. Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data. Biomedicines. 2022; 10(8):1866. 
  2. Zolotovskaia, M., Kovalenko, M.A., Tkachev, V., Simonov, A., Sorokin, M., Kim, E., Kuzmin, D., Karademir-Yilmaz, B., Buzdin, A.A. Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways (2022) International Journal of Molecular Sciences, 23 (13).
  3. Raevskiy, M., Sorokin, M., Zakharova, G., Tkachev, V., Borisov, N., Kuzmin, D., Kremenchutckaya, K., Gudkov, A., Kamashev, D., Buzdin, A. Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level(2022) International Journal of Molecular Sciences, 23 (5), art. no. 2611,
  4. Zolotovskaia, M.A., Tkachev, V.S., Guryanova, A.A., Simonov, A.M., Raevskiy, M.M., Efimov, V.V., Wang, Y., Sekacheva, M.I., Garazha, A.V., Borisov, N.M., Kuzmin, D.V., Sorokin, M.I., Buzdin, A.A. OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization (2022) Computational and Structural Biotechnology Journal, 20, pp. 2280-2291.
  5. Sorokin, M., Gorelyshev, A., Efimov, V., Zotova, E., Zolotovskaia, M., Rabushko, E., Kuzmin, D., Seryakov, A., Kamashev, D., Li, X., Poddubskaya, E., Suntsova, M., Buzdin, A. RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples(2021) Frontiers in Oncology, 11, art. no. 732644, . DOI: 10.3389/fonc.2021.732644
  6. Sorokin, M., Raevskiy, M., Zottel, A., Šamec, N., Vidmar, M.S., Matjašič, A., Zupan, A., Mlakar, J., Suntsova, M., Kuzmin, D.V., Buzdin, A., Jovčevska, I. Large-scale transcriptomics-driven approach revealed overexpression of crnde as a poor survival prognosis biomarker in glioblastoma (2021) Cancers, 13 (14), art. no. 3419, . DOI: 10.3390/cancers13143419
  7. Zolotovskaia, M., Tkachev, V., Sorokin, M., Garazha, A., Kim, E., Kantelhardt, S.R., Bikar, S.-E., Zottel, A., Šamec, N., Kuzmin, D., Sprang, B., Moisseev, A., Giese, A., Efimov, V., Jovčevska, I., Buzdin, A. Algorithmically deduced FREM2 molecular pathway is a potent grade and survival biomarker of human gliomas(2021) Cancers, 13 (16), art. no. 4117, DOI: 10.3390/cancers13164117
  8. Sorokin M, Borisov N., Kuzmin D, Gudkov A., Zolotovskaia M, Garazha A, Buzdin A. Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways, Frontiers in Genetics, 12, art. no. 617059 Open AccessVolume 129 February 2021 Article number 617059, doi:10.3389/fgene.2021.617059
  9. Kamashev, D., Sorokin, M., Kochergina, I., Drobyshev, A., Vladimirova, U., Zolotovskaia, M., Vorotnikov, I., Shaban, N., Raevskiy, M., Kuzmin, D., Buzdin, A. Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth (2021) Heliyon, 7 (3), art. no. e06394
  10. Sorokin, M., Kholodenko, I., Kalinovsky, D., Shamanskaya, T., Doronin, I., Konovalov, D., Mironov, A., Kuzmin, D., Nikitin, D., Deyev, S., Buzdin, A., Kholodenko, R. RNA sequencing-based identification of ganglioside GD2-positive cancer phenotype(2020) Biomedicines, 8 (6), art. no. 142
  11. Zolotovskaia MA, Tkachev VS, Seryakov AP, Kuzmin DV, Kamashev DE, Sorokin MI, Roumiantsev SA, Buzdin AA. Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer. Cancers (Basel). 2020 Jan 22;12(2). pii: E271. doi: 10.3390/cancers12020271
  12. Zolotovskaia MA, Sorokin MI, Emelianova AA, Borisov NM, Kuzmin DV, Borger P, Garazha AV, Buzdin AA. Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs. Front Pharmacol.2019 Jan 23;10:1. doi: 10.3389/fphar.2019.00001.
  13. Anna A. Emelianova, Denis V. Kuzmin, Pavel V. Panteleev, Maxim Sorokin, Anton A. Buzdin and Tatiana V. Ovchinnikova. Anticancer Activity of the Goat Antimicrobial Peptide ChMAP-28. Front Pharmacol. 2018; 9: 1501
  14. Maltsev, Y., Gusev, E., Maltseva, I., Kulikovskiy, M., Namsaraev, Z., Petrushkina, M., Filimonova, A., Sorokin, B., Golubeva, A., Butaeva, G., Khrushchev, A., Zotko, N., Kuzmin, D. Description of a new species of soil algae, Parietochloris grandis sp. nov., and study of its fatty acid profiles under different culturing condition. (2018) Algal Research, 33, pp. 358-368.
  15. Marggraf MB, Panteleev PV, Emelianova AA, Sorokin MI, Bolosov IA, Buzdin AA, Kuzmin DV, Ovchinnikova TV. Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III Mar Drugs (2018), 16 (12).
  16. Mamaeva A, Namsaraev Z, Maltsev Y, Gusev E, Kulikovskiy M, Petrushkina M, Filimonova A, Sorokin B, Zotko N, Vinokurov V, Kopitsyn D, Petrova D, Novikov A, and Kuzmin D. Simultaneous increase in cellular content and volumetric concentration of lipids in bracteacoccus bullatus cultivated at reduced nitrogen and phosphorus concentrations. Journal of Applied Phycology, 2018. DOI: 10.1007/s10811-018-1471-9
  17. Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Ovchinnikova TV. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin I. Bull Exp Biol Med. 2018 June. doi: 10.1007/s10517-018-4134-6.
  18. Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Balandin SV, Serebrovskaya EO, Belogurova-Ovchinnikova OY, Ovchinnikova TV. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides. Chem Biol Drug Des. 2018, Vol 91, Nо 1, pp 294-303
  19. Sorokin M, Kholodenko R, Grekhova A, Suntsova M, Pustovalova M, Vorobyeva N, Kholodenko I, Malakhova G, Garazha A, Nedoluzhko A, Vasilov R, Poddubskaya E, Kovalchuk O, Adamyan L1, Prassolov V, Allina D, Kuzmin D, Ignatev K, Osipov A, Buzdin A. Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation. Oncotarget. 2017 Dec 27;9(4):5111-5124 IF 5.1
  20. Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Ovchinnikova TV. Effect of N- and C-terminal modifications on cytotoxic properties of antimicrobial peptide tachyplesin I. Bull Exp Biol Med. 2017 Apr;162(6):754-757. doi: 10.1007/s10517-017-3705-2.
  21. Petrushkina, M., Gusev, E., Sorokin, B., Zotko, N., Mamaeva, A., Filimonova, A., Kulikovskiy.M., Maltsev E., Yampolsky I., Guglya E., Vinokurov V., Namsaraev Z.,Kuzmin D. Fucoxanthin production by heterokont microalgae. Algal Research.№24.2017. P.387-393.
  22. Artcibasova AV, Korzinkin MB, Sorokin MI, Shegay PV, Zhavoronkov AA, Gaifullin N, Alekseev BY, Vorobyev NV, Kuzmin DV, Kaprin АD, Borisov NM, Buzdin AA. MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.Cell Cycle. 2016;15(5):689-98. doi: 10.1080/15384101.2016.1147633
  23. Denis V. Kuzmin, Tatyana V. Vinogradova, Eugene P. Kopantzev and Eugene D. Sverdlov. Cre-LoxP Mediated Strong Enhancement of pBIRC5 Promoter Driven Suicide of Cancer Cells with CD/UPRT and Fluorocytosine. The Open Gene Therapy Journal, 2010, 3, 31-39.
  24. Kuzmin D, Gogvadze E, Kholodenko R, Grzela DP, Mityaev M, Vinogradova T, Kopantzev E, Malakhova G, Suntsova M, Sokov D, Ivics Z, Buzdin A. Novel strong tissue specific promoter for gene expression in human germ cells. BMC Biotechnol. 2010 Aug 17;10:58. doi: 10.1186/1472-6750-10-58.
  25. D. K. Slizhikova, M. V. Zinovyeva, D. V. Kuzmin, E. V. Snezhkov, M. I. Shakhparonov, R. I. Dmitriev, N.V. Antipova, L. L. Zavalova, E. D. Sverdlov. Decreased expression of the human immunoglobulin J-chain gene in squamous cell cancer and adenocarcinoma of the lungs. Mol Biol (Mosk). 2007 Jul-Aug;41(4):659-65.
  26. Alekseenko I.V., Kuzmin, D.V., Pleshkan, V.V., Zinovyeva, M.V., Sverdlov E.D. Cytotoxicities of cytosine deaminase and herpes simplex virus thymidine kinase genes in melanoma cells are not affected by the promoter strength Russian Journal of Bioorganic Chemistry. 2013, 39 (6): 745-748.
Educational programs
School structure
© 2001-2022 Moscow Institute of Physics and Technology (National Research University)
Social networks
Language version
Site Search
Help us to improve the site. Hit us up if you find a mistake or have suggestions :)